Research focus
About the research
How can genetic mutations and aberrant protein expressions found in brain tumors improve understanding of their etiology, pathogenesis, and treatment?
Read the full research overview
Roger Edwin McLendon is a Professor of Pathology at Duke. The work draws on the resources of the Preston Robert Brain Tumor Biorepository at Duke. The page reports that Duke work helped identify mutations in Isocitrate Dehydrogenase (IDH1 and IDH2) as a marker of good prognosis in gliomas of adults. Testing for TERT promoter region mutations has also been brought to Duke as another major test for classifying gliomas in adults.
Selected publications
3 listedPeople & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings